MedTrace Logo

Trial Outcomes & Findings for Ezetimibe in Patients Hypo-responsive to Statins (NCT NCT00965055)

NCT ID: NCT00965055

Last Updated: 2019-08-21

Results Overview

Study was not analyzed as only 2 subjects were enrolled and the study was terminated due to lack of enrollment.

Recruitment status

TERMINATED

Study phase

PHASE3

Target enrollment

2 participants

Primary outcome timeframe

6 weeks

Results posted on

2019-08-21

Participant Flow

Participant milestones

Participant milestones
Measure
All Study Participants
Overall Study
STARTED
2
Overall Study
COMPLETED
2
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Ezetimibe in Patients Hypo-responsive to Statins

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: 6 weeks

Population: Study was not analyzed as only 2 subjects were enrolled and the study was terminated due to lack of enrollment.

Study was not analyzed as only 2 subjects were enrolled and the study was terminated due to lack of enrollment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 24 weeks

Population: Study was not analyzed as only 2 subjects were enrolled and the study was terminated due to lack of enrollment.

Outcome measures

Outcome data not reported

Adverse Events

All Study Participants

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ori Ben-Yehuda

UCSD

Phone: 9179697273

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place